Aggressive histological component in subsolid lung adenocarcinoma: priority for resection without delay. (16th August 2022)
- Record Type:
- Journal Article
- Title:
- Aggressive histological component in subsolid lung adenocarcinoma: priority for resection without delay. (16th August 2022)
- Main Title:
- Aggressive histological component in subsolid lung adenocarcinoma: priority for resection without delay
- Authors:
- Yotsukura, Masaya
Nakagawa, Kazuo
Takemura, Chihiro
Yoshida, Yukihiro
Ito, Kimiteru
Watanabe, Hirokazu
Kusumoto, Masahiko
Yatabe, Yasushi
Watanabe, Shun-ichi - Abstract:
- Abstract: Introduction: This study explored the predictors of a histological aggressive component in ground glass opacity-containing lung adenocarcinoma. Methods: Of the 2388 patients who underwent resection for lung cancer at our institute between 2017 and 2020, we collected data on the 501 patients with ground glass opacity-containing adenocarcinoma with a total diameter of ≤2 cm. Using a historical cohort, we identified histological aggressive components that were related to a poor prognosis in early-stage adenocarcinoma. A multivariable analysis was conducted to identify predictors for the presence of a histological aggressive component. Results: Lymphovascular invasion and predominant micropapillary or solid patterns were identified as histological aggressive components by a prognostic analysis using a historical cohort. Of the 501 patients included, 36 (7.2%) had at least one histological aggressive component. A multivariate analysis showed that a consolidation/tumour ratio > 0.5 ( P < 0.01), maximum standardized uptake value on positron emission tomography ≥1.5 ( P = 0.01) and smoking index >20 pack-years ( P = 0.01) were predictors of the presence of a histological aggressive component. A total of 98% of cases without any of the above factors did not have a histological aggressive component. Conclusions: Approximately 7% of ground glass opacity-containing small adenocarcinomas contained histological aggressive component. A consolidation/tumour ratio > 0.5, maximumAbstract: Introduction: This study explored the predictors of a histological aggressive component in ground glass opacity-containing lung adenocarcinoma. Methods: Of the 2388 patients who underwent resection for lung cancer at our institute between 2017 and 2020, we collected data on the 501 patients with ground glass opacity-containing adenocarcinoma with a total diameter of ≤2 cm. Using a historical cohort, we identified histological aggressive components that were related to a poor prognosis in early-stage adenocarcinoma. A multivariable analysis was conducted to identify predictors for the presence of a histological aggressive component. Results: Lymphovascular invasion and predominant micropapillary or solid patterns were identified as histological aggressive components by a prognostic analysis using a historical cohort. Of the 501 patients included, 36 (7.2%) had at least one histological aggressive component. A multivariate analysis showed that a consolidation/tumour ratio > 0.5 ( P < 0.01), maximum standardized uptake value on positron emission tomography ≥1.5 ( P = 0.01) and smoking index >20 pack-years ( P = 0.01) were predictors of the presence of a histological aggressive component. A total of 98% of cases without any of the above factors did not have a histological aggressive component. Conclusions: Approximately 7% of ground glass opacity-containing small adenocarcinomas contained histological aggressive component. A consolidation/tumour ratio > 0.5, maximum standardized uptake value ≥ 1.5 and smoking index >20 pack-years were predictors for such cases. These predictors may be useful for screening patients with a potentially high risk of a poor prognosis and for prioritizing resection without delay. Abstract : Our analysis showed that ~7% of subsolid adenocarcinomas contained histological aggressive component. The consolidation/tumour ratio, maximum standardized uptake value and smoking index were predictors for such cases. Graphical Abstract: … (more)
- Is Part Of:
- Japanese journal of clinical oncology. Volume 52:Number 11(2022)
- Journal:
- Japanese journal of clinical oncology
- Issue:
- Volume 52:Number 11(2022)
- Issue Display:
- Volume 52, Issue 11 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 11
- Issue Sort Value:
- 2022-0052-0011-0000
- Page Start:
- 1321
- Page End:
- 1326
- Publication Date:
- 2022-08-16
- Subjects:
- lung adenocarcinoma -- surgery -- prognosis -- ground glass opacity
Oncology -- Periodicals
Cancer -- Periodicals
616.994005 - Journal URLs:
- http://jjco.oupjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/jjco/hyac131 ↗
- Languages:
- English
- ISSNs:
- 0368-2811
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4651.378000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24325.xml